source
- Overlooked drugs can gain value when markets evolve, says Azurity CEORon Scarboro, chief executive of Azurity Pharmaceuticals, wrote about how medicines that seemed unsuccessful can become valuable when market conditions change. He argues that the industry often co…
- FDA Commissioner Highlights New Rare Disease Framework Emphasizing Patient VoiceActing US Food and Drug Administration (FDA) Commissioner Kyle Diamantas highlighted the agency's new rare disease framework during a fireside chat at the NORD Breakthrough Summit. The framework i…